TipRanks
Go Ultimate55% OFF

Lakewood-Amedex Biotherapeutics Inc. (LABT) Financial Statements

Lakewood-Amedex Biotherapeutics Inc. Financial Overview

Lakewood-Amedex Biotherapeutics Inc.'s market cap is currently $473.94K. The company's EPS TTM is $-10.02; its P/E ratio is -0.02; Lakewood-Amedex Biotherapeutics Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25
Income Statement
Total Revenue$ 0.00
Gross Profit$ 0.00
Operating Income$ -3.77M
EBITDA$ -3.63M
Net Income$ -3.85M
Balance Sheet
Cash & Short-Term Investments$ 236.40K
Total Assets$ 481.60K
Total Debt$ 1.66M
Net Debt$ 1.42M
Total Liabilities$ 2.45M
Stockholders' Equity$ -1.96M
Cash Flow
Free Cash Flow$ -1.94M
Operating Cash Flow$ -1.94M
Investing Cash Flow$ 0.00
Financing Cash Flow$ 1.50M

Currency in USD

Lakewood-Amedex Biotherapeutics Inc. Earnings and Revenue History

-4.5M-3M-1.5M00 %0.4 %0.8 %1.2 %EarningsProfit Margin2025RevenueEarningsProfit Margin

Lakewood-Amedex Biotherapeutics Inc. Debt to Assets

01M2M3M506 %507 %508 %509 %LiabilitiesDebt to Assets2025AssetsLiabilitiesDebt to Assets

Lakewood-Amedex Biotherapeutics Inc. Cash Flow

-3M-2M-1M01M2M2025OperatingInvestingFinancing

Lakewood-Amedex Biotherapeutics Inc. Forecast EPS vs Actual EPS